Thread by @EBRheum

Epic editorial just published in @jrheum re:@ACRheum 2019 osteoarthritis recommendations

In short, ACR took the (correct!) stance that we should recommend AGAINST hyaluronic acid

This somewhat understandably upset companies that produce this voodoo. So they wrote an editorial!

Right up front, we get the "I'm not biased, you're biased!" accusation

It's pretty rich for authors who literally worked for and actively own stock in OrthogenRx (a purveyor of fine hyaluronic acid) accuse others of "bias"

Oh, also, OrthogenRx "funded" this editorial

Really - who needs funding to write an editorial? It's like 1200 words and a figure. I've written tweetorials that long while driving

I suppose it was nice to have AOIC LLC, which OrthogenRx funded, make your figure, edit your paper, add refs, and submit the article

This sentence goes down in the #EBM pantheon

The day I spend time reading a "metaanalysis of 12 overlapping metaanalyses" is the day I quite medicine and start up a snake oil company

What does it even mean to meta analyze a dozen meta analyses?

Really though I'm thankful to AOIC LLC for the figure they made

Mostly because I'm proud of the ACR for standing up for #EBM

It aptly illustrates how much courage that takes and how divergent the conclusions of a guideline committee that relies on EBM can be

Kudos ACR.